Skip to Main Content

Advertisement

Issue Archive

Table of Contents

BLOOD COMMENTARIES

IMMUNOBIOLOGY AND IMMUNOTHERAPY
CLINICAL TRIALS AND OBSERVATIONS
Lymphoid Neoplasia
MYELOID NEOPLASIA
Red Cells, Iron, and Erythropoiesis
THROMBOSIS AND HEMOSTASIS

PLENARY PAPER

IMMUNOBIOLOGY AND IMMUNOTHERAPY

There is a Blood Commentary on this article in this issue.

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

LYMPHOID NEOPLASIA

There is a Blood Commentary on this article in this issue.

MYELOID NEOPLASIA

There is a Blood Commentary on this article in this issue.

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

LETTERS TO BLOOD

There is a Blood Commentary on this article in this issue.

There is a Blood Commentary on this article in this issue.

BLOOD WORK

  • Cover Image

    Cover Image

    issue cover

    Phosphatidylinositol 3-kinase δ inhibitor (iPI3K-δ)–resistant murine Eμ-TCL1 tumors stained with forkhead box O1 (FOXO1) and DAPI (4′,6-diamidino-2-phenylindole). Notice the FOXO1 localization in the nucleus upon exposure to iPI3K-δ, which leads to an increase in insulin-like growth factor 1 receptor expression and downstream signaling. See the article by Scheffold et al on page 534.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkTable of Contents
  • PDF Icon PDF LinkBack Matter
  • PDF Icon PDF LinkEditorial Board
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal

Advertisement